NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
Educational resources
Non-alcoholic steatohepatitis: identification, management, and referral pathways
The content on this page is intended for UK healthcare professionals only.